These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 16188182

  • 1. Prospective, double-blind, randomized, parallel-group, dose-ranging study of botulinum toxin type A in men with glabellar rhytids.
    Carruthers A, Carruthers J.
    Dermatol Surg; 2005 Oct; 31(10):1297-303. PubMed ID: 16188182
    [Abstract] [Full Text] [Related]

  • 2. Dose-ranging study of botulinum toxin type A in the treatment of glabellar rhytids in females.
    Carruthers A, Carruthers J, Said S.
    Dermatol Surg; 2005 Apr; 31(4):414-22; discussion 422. PubMed ID: 15871316
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparative evaluation of the safety and efficacy of botulinum toxin type A and topical creams for treating moderate-to-severe glabellar rhytids.
    Beer KR.
    Dermatol Surg; 2006 Feb; 32(2):184-97. PubMed ID: 16442037
    [Abstract] [Full Text] [Related]

  • 5. A prospective, double-blind, randomized, parallel- group, dose-ranging study of botulinum toxin type a in female subjects with horizontal forehead rhytides.
    Carruthers A, Carruthers J, Cohen J.
    Dermatol Surg; 2003 May; 29(5):461-7. PubMed ID: 12752512
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of fresh versus refrigerated botulinum toxin in the treatment of lateral periorbital rhytids.
    Hui JI, Lee WW.
    Ophthalmic Plast Reconstr Surg; 2007 May; 23(6):433-8. PubMed ID: 18030112
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Correlation of botulinum toxin dose with neurophysiological parameters of efficacy and safety in the glabellar muscles: a double-blind, placebo-controlled, randomized study.
    Alimohammadi M, Andersson M, Punga AR.
    Acta Derm Venereol; 2014 Jan; 94(1):32-7. PubMed ID: 23975053
    [Abstract] [Full Text] [Related]

  • 10. Double-blind, randomized, placebo-controlled, dose-response study of the safety and efficacy of botulinum toxin type A in subjects with crow's feet.
    Lowe NJ, Ascher B, Heckmann M, Kumar C, Fraczek S, Eadie N, Botox Facial Aesthetics Study Team.
    Dermatol Surg; 2005 Mar; 31(3):257-62. PubMed ID: 15841623
    [Abstract] [Full Text] [Related]

  • 11. Botulinum toxin A (Botox Cosmetic): a review of its use in the treatment of glabellar frown lines.
    Frampton JE, Easthope SE.
    Am J Clin Dermatol; 2003 Mar; 4(10):709-25. PubMed ID: 14507232
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Glabellar Lines: A Meta-Analysis of Randomized, Placebo-Controlled, Double-Blind Trials.
    Guo Y, Lu Y, Liu T, Zhou Y, Yang P, Zhu J, Chen L, Yang Q.
    Plast Reconstr Surg; 2015 Sep; 136(3):310e-318e. PubMed ID: 26313835
    [Abstract] [Full Text] [Related]

  • 14. A comparison of two botulinum type a toxin preparations for the treatment of glabellar lines: double-blind, randomized, pilot study.
    Lowe PL, Patnaik R, Lowe NJ.
    Dermatol Surg; 2005 Dec; 31(12):1651-4. PubMed ID: 16336882
    [Abstract] [Full Text] [Related]

  • 15. Randomized, placebo-controlled study of a new botulinum toxin type a for treatment of glabellar lines: efficacy and safety.
    Brandt F, Swanson N, Baumann L, Huber B.
    Dermatol Surg; 2009 Dec; 35(12):1893-901. PubMed ID: 19549186
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar Lines.
    Kerscher M, Fabi S, Fischer T, Gold M, Joseph J, Prager W, Rzany B, Yoelin S, Roll S, Klein G, Maas C.
    J Drugs Dermatol; 2020 Oct 01; 19(10):985-991. PubMed ID: 33026771
    [Abstract] [Full Text] [Related]

  • 20. Dilution volume of botulinum toxin type A for the treatment of glabellar rhytides: does it matter?
    Carruthers A, Carruthers J, Cohen J.
    Dermatol Surg; 2007 Jan 01; 33(1 Spec No.):S97-104. PubMed ID: 17241422
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.